ArticleHealth science reports2026
Prevalence, Associated Factors, and Evaluation of Clinical and Biochemical Indices of Gestational Trophoblastic Tumors in Patients Referring to Imam Reza Hospital, Kermanshah: A Five-Year Analytical Study (2017-2022).
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Gestational trophoblastic neoplasia (GTN) encompasses a spectrum of pregnancy-related disorders and poses significant clinical challenges. Understanding its prevalence, clinical characteristics, and associated risk factors is essential for timely diagnosis and management. This study aimed to evaluate the prevalence, clinical and biochemical features, and associated factors of GTN patients admitted to a tertiary referral center in northwestern Iran. Materials and Methods: A cross-sectional, descriptive-analytical study was conducted on all women diagnosed with GTN at Imam Reza Hospital, Kermanshah, between 2017 and 2022. Data were collected retrospectively from both electronic and paper-based medical records using a standardized checklist. Variables included demographics, obstetric and medical history, clinical signs, biochemical markers (β-hCG), treatment modalities, and metastatic status. Descriptive statistics were analyzed using SPSS v26. Results: Among 30,133 deliveries during the study period, 382 GTN cases were identified, yielding a prevalence of 1.27%. Complete mole was the most frequent subtype (56.8%), followed by partial mole (37.7%). Vaginal bleeding (85.6%) and uterine enlargement (74.6%) were the most common clinical presentations. Blood group A was the most prevalent (47.4%), and 15.4% of patients had a history of consanguineous marriage. Uterine evacuation was the primary treatment (85.3%), with chemotherapy and hysterectomy used as indicated. Metastatic disease was observed in 7.6% of patients, predominantly affecting the lungs. Conclusion: GTN represents a notable health concern in this region, with complete mole being the most common form. Age, educational level, blood group, and prior molar pregnancy were identified as relevant factors. Early recognition based on clinical and biochemical markers, alongside structured follow-up, is crucial to optimizing outcomes. These findings underscore the importance of awareness, education, and comprehensive care strategies for high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.